Detalhe da pesquisa
1.
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
N Engl J Med
; 380(3): 229-241, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650326
2.
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
N Engl J Med
; 380(3): 215-228, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650322
3.
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Antimicrob Agents Chemother
; 60(12): 7321-7332, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27697758
4.
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Lancet Child Adolesc Health
; 6(2): 86-95, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871570
5.
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers.
Drug Saf
; 42(9): 1103-1114, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31187437